Andrea Ezquerra
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Andrea Ezquerra has a total of 5 co-authors. Here are the top co-authors by number of shared publications:
- Carlos Delgado-Miguel
Pediatric Surgery Department, Hospital Universitario Fundación Jiménez Díaz, Madrid, Spain
1 shared publication - Juan Carlos López Gutiérrez
Department of Pediatric Surgery, University Hospital La Paz, Madrid, Spain
1 shared publication - María de Ceano-Vivas
Paediatric Emergency Medicine Department, Hospital Infantil, Hospital Universitario La Paz
1 shared publication - Mercedes Díaz
Pediatric Burn Unit, Department of Pediatric Surgery, La Paz Children’s Hospital, 28046 Madrid, Spain
1 shared publication - Miriam Miguel-Ferrero
Pediatric Surgery Department, La Paz University Hospital, 28046 Madrid, Spain
1 shared publication
Latest Publications
- Open Access
Sedoanalgesia in the Debridement of Pediatric Burns in the Emergency Department: Is It Effective and Safe?
Background: The routine use of sedoanalgesia has increased the number of potential minor surgical procedures that can be performed in the Emergency Department (ED) without requiring general anesthesia and, thus, hospital admission. Our aim is to analyze the effectiveness and safety of the use of sedoanalgesia in childhood burns treated in the ED. Methods: A retrospective study was conducted in burned children in whom burn debridement was performed under sedoanalgesia in the ED between 2017 and 2021 in a tertiary referral center for burns. We collected demographic variables, burn features and the type of sedoanalgesia performed in each case, including its effectiveness and associated adverse effects. Results: A total of 227 patients (118 males, 109 females) were included, with a median age of 25 months. In total, 99.2% of the burns were thermal (69.2% scald burns), with a mean total body surface area (TBSA) burned of 4%. The most commonly used drugs were intravenous ketamine (35.7%), intravenous ketamine + midazolam (15.4%), intranasal fentanyl + midazolam (14.1%) and intranasal fentanyl (10.6%). The effectiveness of sedoanalgesia was considered satisfactory in 95.2% of the cases, with an adverse effect rate of 7.5%, without severe adverse effects reported. Conclusions: The use of sedoanalgesia in the ED in the early treatment of childhood burns achieves high effectiveness and safety. It is postulated as a quality indicator; thus, it should be known by all pediatric healthcare practitioners.
Open AccessSedoanalgesia in the Debridement of Pediatric Burns in the Emergency Department: Is It Effective and Safe?
Background: The routine use of sedoanalgesia has increased the number of potential minor surgical procedures that can be performed in the Emergency Department (ED) without requiring general anesthesia and, thus, hospital admission. Our aim is to analyze the effectiveness and safety of the use of sedoanalgesia in childhood burns treated in the ED. Methods: A retrospective study was conducted in burned children in whom burn debridement was performed under sedoanalgesia in the ED between 2017 and 2021 in a tertiary referral center for burns. We collected demographic variables, burn features and the type of sedoanalgesia performed in each case, including its effectiveness and associated adverse effects. Results: A total of 227 patients (118 males, 109 females) were included, with a median age of 25 months. In total, 99.2% of the burns were thermal (69.2% scald burns), with a mean total body surface area (TBSA) burned of 4%. The most commonly used drugs were intravenous ketamine (35.7%), intravenous ketamine + midazolam (15.4%), intranasal fentanyl + midazolam (14.1%) and intranasal fentanyl (10.6%). The effectiveness of sedoanalgesia was considered satisfactory in 95.2% of the cases, with an adverse effect rate of 7.5%, without severe adverse effects reported. Conclusions: The use of sedoanalgesia in the ED in the early treatment of childhood burns achieves high effectiveness and safety. It is postulated as a quality indicator; thus, it should be known by all pediatric healthcare practitioners.